Grünenthal GmbH, STADA Arzneimittel AG

Poland

All drugs from this manufacturer

  • TRANSTEC 52.5 MCG/H

    The medicine is intended for the treatment of moderate to severe pain in cancer diseases and severe pain in other diseases, if it does not subside after the use of other analgesics. This is not a medicine for the treatment of acute pain.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    buprenorphine 30 mg

    ATC: N02AE01

  • TRANSTEC 70 ΜG/H

    The medicinal product is intended for the treatment of moderate to severe pain in cancer diseases and severe pain in other diseases, if it does not subside after the use of other analgesics.

    Dosage form: plaster, transdermal system

    Active substance Dosage
    buprenorphine 40 mg

    ATC: N02AE01